PTGS1 and cirrhosis of liver: In liver cirrhosis, the level of COX‐2 but not that of COX‐1 was significantly increased, and the use of selective COX‐2 inhibitors in patients with liver cirrhosis was beneficial in reducing inflammation and preventing malignant transformation.63